Related references
Note: Only part of the references are listed.Cancer organoid co-culture model system: Novel approach to guide precision medicine
Jin Yuan et al.
FRONTIERS IN IMMUNOLOGY (2023)
A Review of Circulating Tumor DNA as a Biomarker Guide for Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer
Jehan Yahya et al.
JOURNAL OF GASTROINTESTINAL CANCER (2023)
Patient-derived tumor organoids predict responses to irinotecan-based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
Tao Lv et al.
INTERNATIONAL JOURNAL OF CANCER (2023)
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery
Esmee A. Dijkstra et al.
ANNALS OF SURGERY (2023)
Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer
Lisa S. M. Hofste et al.
EJSO (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Oxaliplatin-based adjuvant chemotherapy rather than fluorouracil-based chemotherapy in rectal cancer is more efficient to decrease distant metastasis and increase survival after preoperative chemoradiotherapy and surgery: a meta-analysis
Jin Ho Song et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2022)
Phase II study of durvalumab following neoadjuvant chemoRT in operable rectal cancer: NSABP FR-2
Thomas J. George et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles
Michael Koukourakis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2022)
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer
Gianluca Mauri et al.
BRITISH JOURNAL OF CANCER (2022)
Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)
Jing Jin et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
Julio Garcia-Aguilar et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal
Edina Dizdarevic et al.
CANCERS (2022)
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer
Andrea Cercek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!
Leyla Ozer et al.
COLORECTAL DISEASE (2021)
Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer
Zhenyu Lin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2021)
An update on the use of immunotherapy in patients with colorectal cancer
Mike Nguyen et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)
A. Bapsi Chakravarthy et al.
ONCOLOGIST (2020)
Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma
Ali Shamseddine et al.
RADIATION ONCOLOGY (2020)
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
Federica Papaccio et al.
CANCERS (2020)
Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Tetsuro Tominaga et al.
PLOS ONE (2019)
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
Yanhong Deng et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma The GEMCAD 1402 Randomized Clinical Trial
Carlos Fernandez-Martos et al.
JAMA ONCOLOGY (2019)
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial
Yong Sang Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
Salo N. Ooft et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
J. Joshua Smith et al.
JAMA ONCOLOGY (2019)
Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B plus (GrzB) cytotoxic T-cells in rectal cancer
Armin Jarosch et al.
ONCOIMMUNOLOGY (2018)
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision
Susana Rosello et al.
CANCER TREATMENT REVIEWS (2018)
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03)
Carmine Pinto et al.
ONCOLOGIST (2018)
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
Johan Erlandsson et al.
LANCET ONCOLOGY (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis
Fahima Dossa et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Systemic Immunity Is Required for Effective Cancer Immunotherapy
Matthew H. Spitzer et al.
CELL (2017)
Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
K. Bujko et al.
ANNALS OF ONCOLOGY (2016)
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis
Andrew G. Renehan et al.
LANCET ONCOLOGY (2016)
A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features
Ramon Salazar et al.
BMC CANCER (2015)
Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
Anne J. Breugom et al.
LANCET ONCOLOGY (2015)
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
Ane L. Appelt et al.
LANCET ONCOLOGY (2015)
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2015)
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial
A. J. Breugom et al.
ANNALS OF ONCOLOGY (2015)
Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study
Fiona G. M. Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The life and legacy of William Ernest Miles (1869-1947): a tribute to an admirable surgeon
Fábio Guilherme Campos
Revista da Associacao Medica Brasileira (2013)
Neoadjuvant Radiotherapy for Rectal Cancer: Adherence to Evidence-Based Guidelines in Clinical Practice
Timothy L. Fitzgerald et al.
WORLD JOURNAL OF SURGERY (2013)
Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
Samuel Y. Ngan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
BEVACIZUMAB, CAPECITABINE, AMIFOSTINE, AND PREOPERATIVE HYPOFRACTIONATED ACCELERATED RADIOTHERAPY (HYPOARC) FOR RECTAL CANCER: A PHASE II STUDY
Michael I. Koukourakis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer
Monique Maas et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn et al.
LANCET ONCOLOGY (2011)
PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
Christopher H. Crane et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
The Natural History of Rectal Cancer 1908-2008: The Evolving Treatment of Rectal Cancer into the Twenty-First Century
Warren E. Enker
SEMINARS IN COLON AND RECTAL SURGERY (2010)
Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
Mark S. Roh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
David Sebag-Montefiore et al.
LANCET (2009)
Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study
G. Brown et al.
BRITISH MEDICAL JOURNAL (2006)
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:: Results of FFCD 9203
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
K. Bujko et al.
BRITISH JOURNAL OF SURGERY (2006)
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-Francois Bosset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy - Long-term results
A Habr-Gama et al.
ANNALS OF SURGERY (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
E Kapiteijn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
N Wolmark et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)